1.7100
-0.0600
(-3.39%)
As of 1:05:23 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
233,147
222,506
250,951
305,706
Total Liabilities Net Minority Interest
266,798
256,479
237,379
228,136
Total Equity Gross Minority Interest
-33,651
-33,973
13,572
77,570
Total Capitalization
141,075
139,780
162,856
226,652
Common Stock Equity
-33,651
-33,973
13,572
77,570
Capital Lease Obligations
3,037
5,875
8,193
10,413
Net Tangible Assets
-33,651
-33,973
13,572
77,570
Working Capital
117,557
109,089
123,080
183,365
Invested Capital
141,075
139,780
162,856
226,652
Tangible Book Value
-33,651
-33,973
13,572
77,570
Total Debt
177,763
179,628
157,477
159,495
Net Debt
148,924
145,076
133,920
58,541
Share Issued
152,094.9120
150,285.0440
119,155
102,005
Ordinary Shares Number
152,094.9120
150,285.0440
119,155
102,005
12/31/2021 - 8/26/1987
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARDX Ardelyx, Inc.
4.2150
-2.65%
KPTI Karyopharm Therapeutics Inc.
3.9950
+0.88%
XERS Xeris Biopharma Holdings, Inc.
3.9750
-3.75%
SLRN Acelyrin, Inc.
2.1250
+2.17%
TSHA Taysha Gene Therapies, Inc.
1.1200
-0.88%
GOSS Gossamer Bio, Inc.
0.8111
+2.93%
ANNX Annexon, Inc.
1.3750
-10.61%
ATRA Atara Biotherapeutics, Inc.
5.32
-4.83%
VTYX Ventyx Biosciences, Inc.
0.8815
-3.62%
AMLX Amylyx Pharmaceuticals, Inc.
3.2150
-2.87%